MoneyWorks4Me

UK MHRA completes inspection of Wockhardt’s manufacturing unit in Aurangabad

06 Oct 2015 Evaluate

Wockhardt’s inspection of its manufacturing unit at L-1, Chikalthana, Aurangabad by UK MHRA has been completed and there were no critical observations.

Wockhardt is one of the few companies with end to end integrated capabilities for its products, starting with the manufacture of the oral and sterile API’s, the dose forms and marketing through wholly owned subsidiary in the US, enabling the company to capture maximum value.


Peers
Company Name CMP
Sun Pharma. Inds. 1782.00
Dr. Reddys Labs. 1208.00
Cipla 1334.00
Lupin 2010.00
Zydus Lifesciences 1138.50
View more..